Perfect Medical Industry Co., Ltd. - Laporan Laba Rugi (TTM)

Perfect Medical Industry Co., Ltd.
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Perfect Medical Industry Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 754 808 841 875 800 725 679 633 655 677 680 684 709 734 747 761 752 744 741 737
Change (%) 7.06 4.16 4.00 -8.59 -9.40 -6.31 -6.74 3.47 3.35 0.49 0.49 3.69 3.55 1.80 1.77 -1.08 -1.09 -0.46 -0.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 540 555 572 589 552 515 491 468 505 543 544 546 540 534 527 521 514 506 511 515
Change (%) 2.69 3.08 2.99 -6.29 -6.71 -4.58 -4.80 7.98 7.39 0.27 0.27 -1.10 -1.11 -1.16 -1.18 -1.46 -1.48 0.94 0.93
% of Revenue 71.64 68.71 68.00 67.34 69.04 71.08 72.40 73.91 77.13 80.15 79.97 79.79 76.11 72.68 70.56 68.52 68.26 67.99 68.95 69.91
Gross Operating Profit 214 253 269 286 248 210 187 165 150 134 136 138 169 201 220 239 239 238 230 222
Change (%) 18.11 6.54 6.14 -13.34 -15.40 -10.58 -11.83 -9.32 -10.28 1.40 1.38 22.58 18.42 9.69 8.83 -0.26 -0.26 -3.44 -3.56
% of Revenue 28.36 31.29 32.00 32.66 30.96 28.92 27.60 26.09 22.87 19.85 20.03 20.21 23.89 27.32 29.44 31.48 31.74 32.01 31.05 30.09
SG&A 107 115 129 142 144 146 141 136 130 124 121 119 127 135 139 143 140 138 135 132
Change (%) 7.44 11.39 10.22 1.40 1.38 -3.45 -3.57 -4.43 -4.63 -2.02 -2.07 6.81 6.38 3.01 2.92 -1.84 -1.87 -2.23 -2.28
% of Revenue 14.24 14.29 15.28 16.20 17.97 20.11 20.72 21.43 19.79 18.26 17.80 17.35 17.87 18.36 18.58 18.79 18.64 18.50 18.17 17.84
R&D 8 8 7 6 6 6 6 6 7 7 7 8 7 7 7 8 8 9 11 12
Change (%) -0.43 -9.93 -11.02 -4.00 -4.16 4.69 4.48 8.30 7.67 3.10 3.01 -1.06 -1.08 1.28 1.27 11.28 10.13 14.27 12.49
% of Revenue 1.01 0.94 0.81 0.69 0.73 0.77 0.86 0.96 1.01 1.05 1.08 1.11 1.06 1.01 1.00 1.00 1.12 1.25 1.44 1.62
OpEx 656 678 708 737 702 666 638 610 642 673 673 672 674 676 674 672 662 653 656 659
Change (%) 3.43 4.35 4.17 -4.79 -5.03 -4.25 -4.44 5.23 4.97 -0.12 -0.12 0.30 0.30 -0.30 -0.30 -1.40 -1.42 0.46 0.46
% of Revenue 86.89 83.94 84.09 84.23 87.73 91.96 93.98 96.30 97.93 99.46 98.85 98.25 95.04 92.05 90.15 88.31 88.03 87.74 88.55 89.37
Operating Income 99 130 134 138 98 58 41 23 14 4 8 12 35 58 74 89 90 91 85 78
Change (%) 31.12 3.19 3.09 -28.89 -40.64 -29.88 -42.61 -42.21 -73.04 114.01 53.27 193.65 65.95 26.18 20.75 1.31 1.29 -7.07 -7.60
% of Revenue 13.11 16.06 15.91 15.77 12.27 8.04 6.02 3.70 2.07 0.54 1.15 1.75 4.96 7.95 9.85 11.69 11.97 12.26 11.45 10.63
Interest Expense -2 -2 -2 -3 -3 -3 -3 -4 -4 -4 -5 -5 -5 -4 -4 -4 -4 -4 -4 -5
Change (%) 22.75 15.88 13.70 4.77 4.55 14.56 12.71 8.26 7.63 3.05 2.96 -3.82 -3.97 -4.58 -4.80 -3.14 -3.24 13.04 11.53
% of Revenue -0.22 -0.25 -0.28 -0.31 -0.35 -0.41 -0.50 -0.60 -0.63 -0.66 -0.68 -0.69 -0.64 -0.60 -0.56 -0.52 -0.51 -0.50 -0.57 -0.64
Net Income 77 101 104 106 73 39 28 17 15 14 17 20 30 40 55 70 80 89 81 72
Change (%) 30.42 2.88 2.80 -31.80 -46.62 -28.52 -39.89 -7.17 -7.73 21.50 17.70 48.22 32.53 37.61 27.33 13.44 11.85 -9.34 -10.30
% of Revenue 10.23 12.47 12.31 12.17 9.08 5.35 4.08 2.63 2.36 2.11 2.55 2.98 4.27 5.46 7.38 9.24 10.59 11.98 10.91 9.83

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista